The Petten High Flux Reactor in Petten, Netherlands. Image by Tetzemann - Own work, CC BY 3.0, https://commons.wikimedia.org/w/index.php?curid=83953498
February 2, 2022 —Nuclear Medicine Europehas announced that theHFR reactorin Petten, Netherlands,did not resume operations as plannedon January 20 due to the detection of a water leak in a cooling system. The planned first 2022 HFR cycle scheduled from January 20 until February 20, 2022 was subsequently canceled. The Nuclear Medicine Europe Emergency Response Team held another call on January 31 with representatives of HFR reactor operatorNRG并被告知，HFR检查和恢复功能的方案进展顺利。已经对难以进入的管道进行了内窥镜检查，观察结果为泄漏的来源提供了强有力的指示，并为评估根本原因提供了重要信息。HFR项目团队已经确定了恢复功能的不同选项，并打算在本周内选择首选选项。NRG已经与荷兰核安全管理局ANVS讨论了一种方法的通用计划。目前，还不能确定重启HFR的目标日期，因为这取决于首选技术方案的选择和规划的进一步制定。NRG将于2022年2月7日(星期一)提供下一次更新。The ERT was also given updates from research reactors and Mo-99 producers in regard to actions underway to limit impacts onMo-99/Tc-99m supply. However, some shortages of Mo-99/Tc-99m will be inevitable untinul approximately a week after the BR2 resumes operations on February 12th. Reports also indicated some impact on bothLu-177和i - 131的可用性。医疗机构应与其放射性同位素供应商联系，以确定对其订单的具体影响。NMEu将于2022年2月7日与利益相关方再次沟通。
Related Content:
SNMMI Issues Alert That HFR Outage Will Impact Isotope Supply
How Nuclear Fusion is Revolutionizing Medical Isotope Production
FDA Approves Additional Molybdenum-99 (Mo-99) Filling Lines at NorthStar Medical Radioisotopes
Medical Isotope Industry Opposes Export of Highly Enriched Uranium for IRE
IBA and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Tc-99m
August 10, 2022
